Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | 5. nov 2024 | 26.06 | +0.46 |
Regis | RGS | 5. nov 2024 | 23.37 | +7.20 |
Regulus Therapeutics | RGLS | 5. nov 2024 | 1.49 | 0.00 |
Reinsurance Group of America | RGA | 5. nov 2024 | 212.96 | +0.67 |
REIT Index ETF Vanguard | VNQ | 5. nov 2024 | 95.38 | +1.33 |
Reitar Logtech | RITR | 5. nov 2024 | 6.55 | 0.00 |
Rekor Systems | REKR | 5. nov 2024 | 1.10 | +1.85 |
Relay Therapeutics | RLAY | 5. nov 2024 | 5.95 | +1.71 |
Reliance | RS | 5. nov 2024 | 291.70 | +0.92 |
Reliance Global | RELI | 5. nov 2024 | 2.25 | +1.35 |
Relmada Therapeutics | RLMD | 5. nov 2024 | 3.32 | -2.92 |
RELX ADR | RELX | 5. nov 2024 | 47.91 | +1.81 |
Remitly Global | RELY | 5. nov 2024 | 19.36 | +2.27 |
Renaissance Ipo ETF | IPO | 5. nov 2024 | 45.15 | +1.85 |
RenaissanceRe | RNR | 5. nov 2024 | 269.29 | +1.05 |
RenaissanceRe G Pref | RNR-G | 5. nov 2024 | 18.62 | 0.00 |
RenaissanceRe Holding F Pref | RNR-F | 5. nov 2024 | 24.59 | +0.83 |
Renalytix ADR | RNLX | 5. nov 2024 | 0.20 | 0.00 |
Renasant | RNST | 5. nov 2024 | 34.06 | +2.47 |
Reneo Pharmaceuticals | RPHM | 5. nov 2024 | 1.82 | 0.00 |
ReNew Energy Global A Shares | RNW | 5. nov 2024 | 5.67 | +2.16 |
Renn Fund | RCG | 5. nov 2024 | 2.22 | +1.83 |
Renovaro Biosciences | RENB | 5. nov 2024 | 0.59 | -4.16 |
RenovoRx | RNXT | 5. nov 2024 | 1.04 | 0.00 |
Rent The Runway A | RENT | 5. nov 2024 | 11.08 | +12.49 |
Rentokil Initial ADR | RTO | 5. nov 2024 | 26.45 | +3.44 |
Repare Therapeutics | RPTX | 5. nov 2024 | 3.90 | +8.94 |
Repay A | RPAY | 5. nov 2024 | 8.16 | +1.24 |
Repligen | RGEN | 5. nov 2024 | 145.95 | +4.60 |
Replimune Group | REPL | 5. nov 2024 | 12.02 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.